The government has granted a one-year extension to small and medium-sized pharmaceutical companies (with annual turnover below Rs 250 crore) to meet the revised Schedule M standards, which set quality standards and good manufacturing practices (GM...
AstraZeneca Pharma India is set to sell its 64-acre production facility in North Bengaluru as part of a strategic review of its global manufacturing and supply network by its parent company. The deal is expected to generate over ?3,200 crore and a...
Sanofi Healthcare India has received marketing authorization for Rezurock (belumosudil tablets) in India for the treatment of chronic Graft-versus-host disease (cGVHD) in patients aged 12 years and above.Rezurock is used globally for cGVHD pati...
India's pharma exports are expected to double to USD 65 billion by 2030 and touch USD 350 billion in value terms by 2047, moving to top five position globally by diversifying its product basket, according to a report.
The Indian government has officially withdrawn its track-and-trace system for pharmaceutical exports, nearly 14 years after its introduction. The decision comes just before the latest extension, which was set to be valid until February 1, 2025...
Sun Pharmaceutical Industries Limited and Philogen S.p.A. have reported the successful conclusion of patient enrollment in the Phase III FIBROSARC trial for Soft Tissue Sarcoma (STS). All current Fibromun trials are progressing according to their...
Essential Pharma, a global specialty pharmaceutical organization dedicated to providing patients with access to low volume, clinically distinct niche pharmaceutical products in vital therapeutic fields, and Clinigen, the worldwide specialty...
The independent research organization BioMed X has finalized its oncology research initiative in collaboration with Merck, whose data has been obtained by Merck for additional development, possibly resulting in innovative therapeutic methods in...
Dr. Reddy's Laboratories announced that its subsidiary has signed a licensing agreement with Shanghai Henlius Biotech, Inc. to develop and market a cancer drug currently in development. Dr Reddy's Laboratories SA has signed an agreement with the...
Uniphar, a global partner for pharmaceutical and medtech manufacturers, is enhancing its international reach by opening three new facilities, strategically located in major global markets such as Raleigh, Lelystad, and Dublin. Uniphar's recent...
, CDSCO.jpg)
